Hattersheim, Germany

Walter Duerckheimer

This inventor holds 1 USPTO granted patent. Top assignee: Roussel Uclaf. Active years: 1980.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1980

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Walter Duerckheimer: Innovator in Antibiotic Development

Introduction

Walter Duerckheimer is a notable inventor based in Hattersheim, Germany. He has made significant contributions to the field of antibiotic research. His work focuses on developing novel compounds that exhibit strong antibacterial properties.

Latest Patents

Duerckheimer holds a patent for a novel stable crystalline hydrate of the D form of the syn isomer of sodium 3-acetoxymethyl-7-[2-(2-amino-4-thiazolyl)-2-methoxyimino-acetamido]-ceph-3-eme-4-carboxylate. This compound demonstrates excellent antibiotic activity against both gram-negative and gram-positive bacteria. The patent outlines a process for its preparation, showcasing Duerckheimer's innovative approach to antibiotic development.

Career Highlights

Walter Duerckheimer is associated with Roussel Uclaf, a company known for its contributions to pharmaceutical research. His work at the company has allowed him to focus on developing effective antibiotic solutions. Duerckheimer's dedication to research has led to advancements in the treatment of bacterial infections.

Collaborations

Duerckheimer has collaborated with notable colleagues, including Dieter Bormann and Jean Jolly. These partnerships have fostered a collaborative environment that enhances the research and development of new antibiotics.

Conclusion

Walter Duerckheimer's contributions to antibiotic research are significant and impactful. His innovative patent reflects his commitment to improving healthcare through effective treatments. His work continues to inspire advancements in the field of pharmaceuticals.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…